7Baggers

Collegium Pharmaceutical Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Goodwill  
 Account Receivables  
 Cash and Cash Eq  
 Account Payables  
 Deferred Revenue  
 Long-Term Debt  
 Inventory  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 040.5481.07121.61162.14202.68243.21283.75Milllion

Collegium Pharmaceutical Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 
                                            
  assets                                          
  current assets                                          
  cash and cash equivalents117,348,000 96,192,000 70,565,000 38,960,000 172,894,000 228,610,000 238,947,000 258,532,000 283,749,000 269,480,000 173,688,000 134,126,000 122,722,000 106,698,000 186,426,000 193,241,000 202,771,000 182,790,000 174,116,000 165,423,000 145,678,000 116,178,000 170,019,000 153,838,000 148,713,000 134,910,000 146,633,000 139,790,000 133,747,000 128,249,000 118,697,000 107,611,000 111,209,000 129,558,000 153,225,000 91,028,000 110,747,000 134,730,000 95,697,000 105,460,000 112,413,000 44,989,000 
  marketable securities104,805,000 101,582,000 92,198,000 80,997,000 98,737,000 89,438,000 71,601,000 46,033,000 41,721,000                                  
  accounts receivable213,023,000 228,710,000 228,540,000 228,456,000 183,855,000 174,693,000 179,525,000 181,851,000 167,479,000 179,127,000 183,119,000 195,402,000 197,505,000 166,345,000 105,844,000 148,999,000 90,098,000 93,156,000 83,320,000 76,466,000 81,195,000 85,427,000 72,953,000 84,380,000 81,279,000 85,139,000 77,946,000 66,533,000 68,380,000 66,036,000  5,823,000 4,877,000 3,349,000  1,679,000 2,952,000      
  inventory38,148,000 37,218,000 35,560,000 38,032,000 27,862,000 31,276,000 32,332,000 34,125,000 26,026,000 32,895,000 46,501,000 64,652,000 77,769,000 80,146,000 17,394,000 17,358,000 19,595,000 15,498,000 15,614,000 17,146,000 18,815,000 15,963,000 9,643,000 8,760,000 9,953,000 8,741,000 7,817,000 9,229,000 8,544,000 7,902,000  1,401,000 1,520,000 1,495,000  1,576,000 1,214,000      
  prepaid expenses and other current assets56,037,000 43,996,000 30,394,000 32,365,000 26,850,000 15,243,000 15,195,000 16,545,000 18,322,000 16,798,000 16,681,000 11,036,000 11,778,000 10,449,000 5,879,000 3,640,000 6,068,000 4,867,000 4,838,000 3,097,000 5,125,000 6,107,000 3,105,000 2,807,000 4,618,000 5,053,000 5,116,000 3,425,000 5,622,000 5,526,000  4,061,000 3,009,000 2,064,000  1,086,000 1,537,000 821,000 1,186,000 866,000 1,219,000 1,838,000 
  restricted cash19,850,000 19,855,000 25,000,000 25,000,000 1,047,000 1,047,000 1,047,000 1,047,000 1,047,000 2,547,000 2,547,000 2,547,000 2,547,000 2,547,000 2,547,000 2,547,000 2,547,000 2,547,000 2,547,000 2,547,000 2,547,000 2,645,000        703,000  97,000 97,000 97,000  97,000 97,000 97,000 97,000 97,000 97,000 97,000 
  total current assets549,211,000 527,553,000 482,257,000 443,810,000 510,198,000 539,260,000 537,600,000 537,086,000 537,297,000 498,300,000 419,989,000 405,216,000 409,774,000 363,638,000 315,543,000 363,238,000 318,532,000 296,311,000 277,888,000 262,132,000 250,813,000 223,675,000 255,720,000 249,785,000 244,563,000 233,843,000 237,512,000 218,977,000 216,293,000 207,713,000  118,896,000 120,615,000 136,466,000  95,369,000 116,450,000 135,551,000 96,883,000 106,326,000 113,632,000 46,827,000 
  property and equipment12,903,000 13,850,000 14,329,000 14,614,000 14,976,000 15,457,000 15,983,000 16,645,000 18,040,000 18,879,000 19,521,000 19,744,000 19,965,000 20,202,000 19,491,000 19,629,000 19,555,000 19,760,000 18,988,000 17,746,000 15,156,000 13,145,000 11,854,000 11,579,000 10,367,000 9,962,000 9,274,000 6,039,000 3,203,000 1,612,000  1,632,000 1,583,000 1,007,000  772,000 676,000 695,000 738,000 627,000 445,000 468,000 
  operating lease assets5,263,000 5,545,000 5,822,000 6,169,000 5,592,000 5,813,000 6,029,000 6,243,000 6,452,000 6,658,000 6,861,000 7,061,000 7,257,000 7,812,000 7,644,000 7,835,000 8,023,000 8,209,000 8,391,000 8,572,000 8,697,000 8,873,000 9,047,000 9,219,000 9,574,000 9,766,000                 
  intangible assets780,456,000 835,930,000 891,402,000 946,875,000 352,676,000 387,191,000 421,708,000 456,222,000 492,539,000 530,002,000 567,468,000 609,747,000 647,299,000 694,799,000         29,503,000 33,191,000 36,879,000 40,567,000 44,255,000 421,287,000 453,694,000 486,100,000  1,877,000 1,925,000 1,973,000  2,273,000 2,500,000      
  deferred tax assets91,967,000 91,665,000 98,033,000 72,509,000 34,184,000 30,671,000 26,259,000 25,738,000 24,606,000 23,969,000 23,950,000 26,474,000 28,571,000 25,554,000 78,042,000 63,026,000 62,649,000                          
  other noncurrent assets3,845,000 5,038,000 8,368,000 4,171,000 858,000 954,000 825,000 740,000 74,000 87,000 100,000 57,000 67,000 77,000 87,000 10,000 115,000 129,000 123,000 147,000 163,000 166,000 178,000 204,000 198,000 224,000                 
  goodwill147,936,000 150,760,000 162,333,000 145,959,000 133,857,000 133,857,000 133,857,000 133,857,000 133,857,000 133,857,000 133,695,000 130,094,000 130,094,000 131,512,000                             
  total assets1,592,631,000 1,631,388,000 1,663,591,000 1,635,154,000 1,053,388,000 1,114,250,000 1,143,308,000 1,177,578,000 1,213,912,000 1,214,299,000 1,174,131,000 1,200,940,000 1,245,574,000 1,246,141,000 692,077,000 741,803,000 713,735,000 646,065,000 643,841,000 643,843,000 646,870,000 634,793,000 306,302,000 303,978,000 301,581,000 294,362,000 291,245,000 646,508,000 673,329,000 696,278,000 135,568,000 122,673,000 124,515,000 139,848,000 162,017,000 98,725,000 119,723,000 136,343,000 97,718,000 107,050,000 114,174,000 47,392,000 
  liabilities and shareholders' equity                                          
  current liabilities                                          
  accounts payable10,890,000 17,853,000 3,934,000 3,142,000 2,412,000 6,020,000 8,692,000 3,653,000 2,420,000 2,992,000 3,494,000 7,637,000 6,627,000 3,851,000 4,189,000 7,730,000 7,543,000 8,666,000 10,016,000 6,491,000 8,182,000 6,139,000 6,247,000 11,981,000 10,941,000 13,733,000 12,150,000 11,679,000 18,692,000 9,336,000  4,982,000 5,612,000 6,793,000  8,970,000 6,074,000 6,189,000 3,537,000 3,237,000 2,239,000 2,180,000 
  accrued liabilities59,436,000 53,740,000 72,124,000 47,600,000 38,726,000 38,190,000 37,571,000 31,651,000                                   
  accrued rebates, returns and discounts310,758,000 324,665,000 338,642,000 313,874,000 236,208,000 217,880,000 227,331,000 245,012,000 213,089,000 200,902,000 230,491,000 241,218,000 246,719,000 227,476,000 196,996,000 191,723,000 143,224,000 156,153,000 156,554,000 170,246,000 171,053,000 171,886,000 157,549,000 165,263,000 158,264,000 152,328,000 144,783,000 130,454,000 107,790,000 92,400,000             
  current portion of term notes payable64,583,000 64,583,000 64,583,000 64,583,000 183,333,000 183,333,000 183,333,000 183,333,000 183,333,000 183,333,000 162,500,000 141,667,000 120,833,000 100,000,000 48,353,000 48,135,000 47,919,000 47,705,000 47,495,000 47,281,000 47,069,000 46,859,000                     
  current portion of operating lease liabilities1,338,000 1,304,000 1,271,000 1,271,000 1,038,000 1,013,000 988,000 963,000 971,000 1,042,000 1,112,000 1,179,000 1,211,000 1,178,000 814,000 793,000 771,000 750,000 730,000 709,000 696,000 676,000 656,000 750,000 633,000 523,000                 
  business combination consideration payable17,566,000 24,565,000 28,956,000 28,956,000                                       
  contingent consideration38,000 396,000 1,182,000 4,096,000                                       
  total current liabilities464,609,000 486,710,000 509,510,000 459,426,000 461,717,000 446,436,000 457,915,000 464,612,000 435,058,000 412,702,000 433,726,000 414,497,000 415,094,000 373,573,000 279,566,000 268,973,000 226,843,000 230,168,000 239,451,000 242,437,000 252,111,000 244,374,000 201,765,000 201,483,000 196,272,000 188,885,000 189,126,000 280,221,000 264,702,000 250,228,000  26,396,000 28,561,000 24,532,000  22,212,000 18,203,000 11,068,000 8,432,000 8,600,000 6,190,000 6,707,000 
  term notes payable, net of current portion520,648,000 535,698,000 550,733,000 565,716,000 132,845,000 177,360,000 221,713,000 265,886,000 309,898,000 353,769,000 397,578,000 441,258,000 484,853,000 528,390,000 61,666,000 73,832,000 85,944,000 98,006,000 110,019,000 121,967,000 133,862,000 145,711,000                     
  convertible senior notes237,688,000 237,429,000 237,172,000 236,911,000 236,650,000 262,425,000 262,125,000 261,823,000 261,521,000 261,222,000 140,873,000 140,644,000 140,415,000 140,189,000 139,966,000 139,738,000 139,511,000 139,286,000 99,575,000 97,795,000 96,046,000 94,383,000                     
  operating lease liabilities, net of current portion4,853,000 5,199,000 5,539,000 5,914,000 5,593,000 5,860,000 6,124,000 6,384,000 6,630,000 6,873,000 7,112,000 7,347,000 7,600,000 7,913,000 7,951,000 8,166,000 8,371,000 8,570,000 8,765,000 8,958,000 9,084,000 9,262,000 9,438,000 9,612,000 9,903,000 10,091,000                 
  deferred royalty obligation122,627,000 121,522,000 120,613,000 118,812,000                                       
  deferred revenue10,000,000 10,000,000 10,000,000 10,000,000                             10,361,000 8,695,000  3,938,000 3,926,000      
  total liabilities1,360,425,000 1,396,954,000 1,434,749,000 1,400,875,000 836,805,000 892,081,000 947,877,000 998,705,000 1,013,107,000 1,034,566,000 979,289,000 1,003,746,000 1,047,962,000 1,050,065,000 489,149,000 490,709,000 460,669,000 476,030,000 457,810,000 471,157,000 491,103,000 493,730,000 218,870,000 219,720,000 215,758,000 208,012,000 199,660,000 575,728,000 590,648,000 605,455,000  26,404,000 29,002,000 25,481,000  24,400,000 21,067,000 14,607,000 12,646,000 13,489,000 11,755,000 12,946,000 
  commitments and contingencies                                          
  shareholders’ equity:                                          
  preferred stock, 0.001 par value; authorized shares - 5,000,000                                          
  common stock40,000 40,000 40,000 40,000 40,000 39,000 38,000 38,000 38,000 38,000 37,000 37,000 37,000 36,000 36,000 36,000 36,000 35,000 35,000 35,000 34,000 34,000 34,000 34,000 33,000 33,000 33,000 33,000 33,000 33,000  31,000 30,000 29,000  24,000 24,000 24,000 21,000 20,000 20,000 1,000 
  additional paid-in capital598,938,000 593,240,000 590,251,000 582,762,000 567,976,000 565,111,000 565,949,000 545,940,000 548,492,000 540,389,000 538,073,000 525,585,000 520,038,000 513,312,000 502,095,000 499,846,000 492,384,000 482,197,000 519,143,000 512,756,000 507,124,000 500,478,000 447,297,000 441,922,000 437,379,000 433,194,000 428,729,000 417,010,000 412,409,000 407,491,000  376,884,000 362,866,000 360,600,000  269,929,000 267,815,000 266,376,000 214,062,000 213,027,000 212,523,000 20,234,000 
  treasury stock-217,510,000 -197,505,000 -197,505,000 -172,381,000 -165,381,000 -137,381,000 -137,381,000 -101,924,000 -61,924,000 -61,924,000 -61,924,000 -54,283,000 -47,861,000 -47,861,000 -42,861,000 -17,480,000                           
  accumulated other comprehensive income337,000 241,000 55,000 393,000 -182,000 -124,000 14,000                                    
  accumulated deficit-149,599,000 -161,582,000 -163,999,000 -176,535,000 -185,870,000 -205,476,000 -233,189,000 -265,129,000 -285,763,000 -298,770,000 -281,344,000 -274,145,000 -274,602,000 -269,411,000 -256,342,000 -231,308,000 -239,354,000 -312,197,000 -333,147,000 -340,105,000 -351,391,000 -359,449,000 -359,899,000 -357,698,000 -351,589,000 -346,877,000 -337,177,000 -346,263,000 -329,761,000 -316,701,000  -280,646,000 -267,383,000 -246,262,000  -195,625,000 -169,180,000 -144,661,000 -129,008,000 -119,483,000   
  total shareholders’ equity232,206,000 234,434,000 228,842,000 234,279,000 216,583,000 222,169,000 195,431,000 178,873,000 200,805,000 179,733,000 194,842,000 197,194,000 197,612,000 196,076,000 202,928,000 251,094,000 253,066,000 170,035,000 186,031,000 172,686,000 155,767,000 141,063,000 87,432,000 84,258,000 85,823,000 86,350,000 91,585,000 70,780,000 82,681,000 90,823,000 104,080,000 96,269,000 95,513,000 114,367,000 134,908,000 74,325,000 98,656,000 121,736,000 85,072,000 93,561,000 102,419,000  
  total liabilities and shareholders’ equity1,592,631,000 1,631,388,000 1,663,591,000 1,635,154,000 1,053,388,000 1,114,250,000 1,143,308,000 1,177,578,000 1,213,912,000 1,214,299,000 1,174,131,000 1,200,940,000 1,245,574,000 1,246,141,000 692,077,000 741,803,000 713,735,000 646,065,000 643,841,000 643,843,000 646,870,000 634,793,000 306,302,000 303,978,000 301,581,000 294,362,000 291,245,000 646,508,000 673,329,000 696,278,000  122,673,000 124,515,000 139,848,000  98,725,000 119,723,000 136,343,000     
  accumulated other comprehensive loss       -52,000 -38,000                                  
  accrued expenses        35,245,000 24,433,000 36,129,000 22,796,000 39,704,000 41,068,000 29,214,000 20,592,000 27,386,000 16,894,000 24,656,000 17,710,000 25,111,000 18,814,000 33,480,000 20,614,000 24,517,000 19,837,000 30,551,000 20,933,000 23,395,000 17,436,000  19,268,000 10,199,000 6,488,000  6,637,000 5,536,000 2,212,000 2,228,000 2,681,000 1,671,000 2,732,000 
  intangible asset              268,723,000 285,518,000 302,314,000 319,109,000 335,904,000 352,699,000 369,494,000 386,289,000                     
  preferred stock, 0.001 par value; authorized shares - 5,000,000 at march 31, 2021 and december 31, 2020; issued and outstanding shares - none at march 31, 2021 and december 31, 2020                                          
  preferred stock, 0.001 par value; authorized shares - 5,000,000 at december 31, 2020 and december 31, 2019; issued and outstanding shares - none at december 31, 2020 and december 31, 2019                                          
  preferred stock, 0.001 par value; authorized shares - 5,000,000 at september 30, 2020 and december 31, 2019; issued and outstanding shares - none at september 30, 2020 and december 31, 2019                                          
  preferred stock, 0.001 par value; authorized shares - 5,000,000 at june 30, 2020 and december 31, 2019; issued and outstanding shares - none at june 30, 2020 and december 31, 2019                                          
  preferred stock, 0.001 par value; authorized shares - 5,000,000 at march 31, 2020 and december 31, 2019; issued and outstanding shares - none at march 31, 2020 and december 31, 2019                                          
  current portion of term loan payable                      3,833,000 2,875,000 1,917,000 2,464,000 1,642,000 821,000    2,146,000 2,389,000 2,556,000  2,667,000 2,667,000 2,667,000 2,667,000 2,667,000 2,250,000 1,750,000 
  term loan payable, net of current portion                      7,667,000 8,625,000 9,583,000 9,036,000                 
  other noncurrent liabilities                                          
  preferred stock, 0.001 par value; authorized shares - 5,000,000 at december 31, 2019 and december 31, 2018; issued and outstanding shares - none at december 31, 2019 and december 31, 2018                                          
  preferred stock, 0.001 par value; authorized shares - 5,000,000 at september 30, 2019 and december 31, 2018; issued and outstanding shares - none at september 30, 2019 and december 31, 2018                                          
  preferred stock, 0.001 par value; authorized shares - 5,000,000 at june 30, 2019 and december 31, 2018; issued and outstanding shares - none at june 30, 2019 and december 31, 2018                                          
  preferred stock, 0.001 par value; authorized shares - 5,000,000 at march 31, 2019 and december 31, 2018; issued and outstanding shares - none at march 31, 2019 and december 31, 2018                                          
  other long-term assets                          204,000 205,000 139,000 150,000  171,000 295,000 305,000  214,000       
  other long-term liabilities                          676,000        1,513,000        
  term loan payable, long-term                          9,858,000 10,679,000 11,500,000 11,500,000   424,000 924,000  2,146,000 2,813,000 3,480,000 4,146,000 4,813,000 5,480,000 6,146,000 
  preferred stock, 0.001 par value; authorized shares - 5,000,000 at december 31, 2018 and december 31, 2017; issued and outstanding shares - none at december 31, 2018 and december 31, 2017                                          
  current portion of asset acquisition obligations                           116,334,000 114,825,000 131,056,000             
  asset acquisition obligations, long-term                           284,828,000 314,446,000 343,727,000             
  preferred stock, 0.001 par value; authorized shares - 5,000,000 at september 30, 2018 and december 31, 2017; issued and outstanding shares - none at september 30, 2018 and december 31, 2017                                          
  preferred stock, 0.001 par value; authorized shares - 5,000,000 at june 30, 2018 and december 31, 2017; issued and outstanding shares - none at june 30, 2018 and december 31, 2017                                          
  preferred stock, 0.001 par value; authorized shares - 5,000,000 at march 31, 2018 and december 31, 2017; issued and outstanding shares - none at march 31, 2018 and december 31, 2017                                          
  balance sheet data:                                          
  working capital                              101,996,000    132,979,000        
  lease incentive obligation                               8,000 17,000 25,000  42,000 51,000 59,000 68,000 76,000 85,000 93,000 
  preferred stock, 0.001 par value; authorized shares - 5,000,000 at september 30, 2017 and december 31, 2016; issued and outstanding shares - none at september 30, 2017 and december 31, 2016                                          
  preferred stock, 0.001 par value; authorized shares - 5,000,000 at june 30, 2017 and december 31, 2016; issued and outstanding shares - none at june 30, 2017 and december 31, 2016                                          
  shareholders’ equity                                          
  preferred stock, 0.001 par value; authorized shares - 5,000,000 at march 31, 2017 and december 31, 2016; issued and outstanding shares - none at march 31, 2017 and december 31, 2016                                          
  preferred stock, 0.001 par value; authorized shares - 5,000,000 at september 30, 2016 and december 31, 2015; issued and outstanding shares - none at september 30, 2016 and december 31, 2015                                          
  current assets:                                          
  current liabilities:                                          
  preferred stock, 0.001 par value; authorized shares 5,000,000 at june 30, 2016 and december 31, 2015; issued and outstanding shares - none at june 30, 2016 and december 31, 2015                                          
  preferred stock, 0.001 par value; authorized shares 5,000,000 at march 31, 2016 and december 31, 2015; issued and outstanding shares - none at march 31, 2016 and december 31, 2015; liquidation preference none at march 31, 2016 and december 31, 2015                                          
  refundable pdufa fee                                          
  liabilities, convertible redeemable preferred stock and shareholders' equity                                          
  current portion of deferred rent and lease note payable                                       15,000 30,000 45,000 
  convertible bridge notes with related parties                                          
  series a convertible redeemable preferred stock, 0.001 par value; authorized shares — none at december 31, 2015 and 18,498,419 at december 31, 2014; issued and outstanding shares — none at december 31, 2015 and 9,232,334 at december 31, 2014; liquidation preference of none at december 31, 2015 and 12,781 at december 31, 2014                                          
  series b convertible redeemable preferred stock, 0.001 par value; authorized shares - none at december 31, 2015 and 27,324,237 at december 31, 2014; issued and outstanding shares - none at december 31, 2015 and 27,324,237 at december 31, 2014; liquidation preference of none at december 31, 2015 and 51,212 at december 31, 2014                                          
  series c convertible redeemable preferred stock, 0.001 par value; authorized shares - none at december 31, 2015 and 8,658,344 at december 31, 2014; issued and outstanding shares - none at december 31, 2015 and 8,658,008 at december 31, 2014; liquidation preference of none at december 31, 2015 and 13,114 at december 31, 2014                                          
  preferred stock, 0.001 par value; authorized shares 5,000,000 at december 31, 2015 and none at december 31, 2014; issued and outstanding shares - none and december 31, 2015 and december 31, 2014; liquidation preference none at december 31, 2015 and december 31, 2014                                          
  total liabilities, convertible redeemable preferred stock and shareholders’ equity                                      97,718,000 107,050,000 114,174,000  
  series a convertible redeemable preferred stock, 0.001 par value; authorized shares — none at september 30, 2015 and 18,498,419 at december 31, 2014; issued and outstanding shares — none at september 30, 2015 and 9,232,334 at december 31, 2014; liquidation preference of none at september 30, 2015 and 12,781 at december 31, 2014                                          
  series b convertible redeemable preferred stock, 0.001 par value; authorized shares - none at september 30, 2015 and 27,324,237 at december 31, 2014; issued and outstanding shares - none at september 30, 2015 and 27,324,237 at december 31, 2014; liquidation preference of none at september 30, 2015 and 51,212 at december 31, 2014                                          
  series c convertible redeemable preferred stock, 0.001 par value; authorized shares - none at september 30, 2015 and 8,658,344 at december 31, 2014; issued and outstanding shares - none at september 30, 2015 and 8,658,008 at december 31, 2014; liquidation preference of none at september 30, 2015 and 13,114 at december 31, 2014                                          
  series d convertible redeemable preferred stock, 0.001 par value; authorized shares - none at september 30, 2015 and december 31, 2014; issued and outstanding shares - none at september 30, 2015 and december 31, 2014; liquidation preference of none at september 30, 2015 and december 31, 2014                                          
  liabilities, convertible redeemable preferred stock and shareholders’ deficit                                          
  series a convertible redeemable preferred stock, 0.001 par value; authorized shares — none at june 30, 2015 and 18,498,419 at december 31, 2014; issued and outstanding shares — none at june 30, 2015 and 9,232,334 at december 31, 2014; liquidation preference of none at june 30, 2015 and 12,781 at december 31, 2014                                          
  series b convertible redeemable preferred stock, 0.001 par value; authorized shares — none at june 30, 2015 and 27,324,237 at december 31, 2014; issued and outstanding shares — none at june 30, 2015 and 27,324,237 at december 31, 2014; liquidation preference of none at june 30, 2015 and 51,212 at december 31, 2014                                          
  series c convertible redeemable preferred stock, 0.001 par value; authorized shares — none at june 30, 2015 and 8,658,344 at december 31, 2014; issued and outstanding shares — none at june 30, 2015 and 8,658,008 at december 31, 2014; liquidation preference of none at june 30, 2015 and 13,114 at december 31, 2014                                          
  series d convertible redeemable preferred stock, 0.001 par value; authorized shares — none at june 30, 2015 and december 31, 2014; issued and outstanding shares — none at june 30, 2015 and december 31, 2014; liquidation preference of none at june 30, 2015 and december 31, 2014                                          
  series a convertible redeemable preferred stock, 0.001 par value; authorized shares — 18,498,419 at march 31, 2015 and december 31, 2014; issued and outstanding shares — 9,232,334 at march 31, 2015 and december 31, 2014; liquidation preference of 11,345 at march 31, 2015 and 12,781 at december 31, 2014                                         11,345,000 
  series b convertible redeemable preferred stock, 0.001 par value; authorized shares — 27,324,237 at march 31, 2015 and december 31, 2014; issued and outstanding shares — 27,324,237 at march 31, 2015 and december 31, 2014; liquidation preference of 45,905 at march 31, 2015 and 51,212 at december 31, 2014                                         45,905,000 
  series c convertible redeemable preferred stock, 0.001 par value; authorized shares — 8,658,344 at march 31, 2015 and december 31, 2014; issued and outstanding shares — 8,658,008 at march 31, 2015 and december 31, 2014; liquidation preference of 12,000 at march 31, 2015 and 13,114 at december 31, 2014                                         12,000,000 
  series d convertible redeemable preferred stock, 0.001 par value; authorized shares — 41,666,667 at march 31, 2015 and none at december 31, 2014; issued and outstanding shares — 41,666,667 at march 31, 2015 and none at december 31, 2014; liquidation preference of 50,411 at march 31, 2015 and none at december 31, 2014                                         50,411,000 
  shareholders’ deficit:                                          
  total shareholders’ deficit                                          
  total liabilities, convertible redeemable preferred stock and shareholders’ deficit                                         47,392,000 
  operating expenses:                                          
  research and development                                         1,445,000 
  general and administrative                                         2,185,000 
  total operating expenses                                         3,630,000 
  income from operations                                          
  other income:                                          
  interest expense                                         155,000 
  gain on extinguishment                                          
  total other income                                         64,000 
  net income                                         -3,694,000 
  earning (loss) per share-basic                                         340 
  earnings per share-diluted                                         -650 
  weighted-average shares-basic                                         1,001,704,000 
  weighted-average shares-diluted                                         7,554,524,000 

We provide you with 20 years of balance sheets for Collegium Pharmaceutical stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Collegium Pharmaceutical. Explore the full financial landscape of Collegium Pharmaceutical stock with our expertly curated balance sheets.

The information provided in this report about Collegium Pharmaceutical stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.